Taihe Hospital affiliated to Hubei University of Medicine | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PregnAncy-Related Aortic DISsEction in China	Abnormalities, Multiple, Acute Aortic Syndrome, Aneurysm, Aortic Dissection, Bone Diseases, Developmental, Cardiovascular Abnormalities, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Dissection, Blood Vessel, Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, vascular type, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Loeys-Dietz syndrome, Marfan syndrome, Musculoskeletal Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, Urogenital Diseases, aortic aneurysm, aortic disorder, bone disorder, cardiovascular disorder, congenital heart disease, connective tissue disorder, heart disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary skin disorder, musculoskeletal system disorder, pregnancy disorder, skin disorder, vascular disorder, vascular hemostatic disease	Recruiting	Not stated	2026-07-17		NCT07672210
Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection	Anastomotic Leak, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm	Recruiting	Not applicable	2026-05-26		NCT07605611
Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Not yet recruiting	Phase 2 / Phase 3	2025-12-18		NCT07240467